Treatment Overview
Genetic Risk Assessment for prostate cancer involves analyzing specific genes and family history to evaluate an individual’s predisposition to developing prostate cancer. This assessment identifies inherited mutations, such as BRCA1, BRCA2, HOXB13, and other risk-related genes, which can influence early detection and personalized screening strategies.
In Korea, genetic risk assessment is performed at advanced hospitals and specialized genetic testing centers using next-generation sequencing (NGS) and comprehensive bioinformatics analysis. International patients benefit from professional counseling, secure sample handling, and timely results.
Purpose & Benefits
The primary purposes of genetic risk assessment are:
- Identify men at higher risk of prostate cancer due to inherited genetic mutations
- Guide personalized screening and monitoring strategies
- Enable informed decision-making for preventive measures
Benefits include:
- Early detection and personalized screening for high-risk individuals
- Identification of hereditary cancer syndromes in families
- Supports targeted interventions such as PSA testing, mpMRI, or early biopsy
- Provides peace of mind for patients and their families
- Internationally recognized testing with expert counseling
Ideal Candidates
Genetic risk assessment is recommended for men who:
- Have a family history of prostate or related cancers
- Carry or suspect hereditary gene mutations
- Are diagnosed with early-onset prostate cancer
- Want to assess familial cancer risk
- Are considering personalized prostate cancer screening plans
Korean genetic counselors review patient history, recommend relevant tests, and provide pre- and post-test counseling.
Possible Risks & Complications
Genetic risk assessment is non-invasive and safe. Considerations include:
- Anxiety or emotional stress from test results
- Rare privacy concerns regarding genetic information
- Limited predictive certainty; a positive result indicates increased risk, not certainty of cancer
- Counseling is provided to interpret results accurately
Techniques & Technology Used
Korean centers use advanced genetic technologies:
- Next-Generation Sequencing (NGS) for comprehensive gene analysis
- BRCA1, BRCA2, HOXB13, and other prostate cancer-related genes
- Bioinformatics analysis to assess pathogenic variants
- Genetic counseling before and after testing
- Secure and confidential sample handling
- Integration with clinical data for personalized screening recommendations
These technologies ensure accurate, actionable results for patients.
Treatment Process in Korea
- Consultation & Risk Evaluation – Review family history, PSA levels, and prior medical records
- Sample Collection – Blood or saliva sample collected in a sterile environment
- Laboratory Analysis – Comprehensive genetic testing and variant analysis
- Result Interpretation & Counseling – Genetic counselors explain findings and implications
- Follow-Up Recommendations – Personalized screening, preventive measures, or referral for biopsy
Medical tourism coordinators assist international patients with scheduling, sample logistics, and English-language support.
Recovery & After-Care
- No significant recovery needed
- Resume normal activities immediately after sample collection
- Emotional support and counseling recommended if high-risk variants are found
- Keep a record of results for future medical decisions and family screening
Results & Interpretation
Genetic testing provides:
- Identification of pathogenic variants associated with prostate cancer
- Assessment of hereditary cancer risk in the patient and family
- Personalized recommendations for screening frequency, imaging, and preventive measures
- Guidance for early interventions or lifestyle modifications
Results help patients and urologists make informed decisions about monitoring, biopsy, or preventive strategies.
Why Korea Is a Top Destination
- Cutting-edge genetic testing laboratories with international standards
- Experienced genetic counselors and urologists
- Fast and accurate results with secure data handling
- English-language support for international patients
- Integration with advanced imaging and prostate diagnostics
- Affordable and high-quality compared to Western countries
Cost Range
Typical costs for genetic risk assessment in Korea:
₩500,000 – ₩2,000,000 KRW (~$400–$1,500 USD)
Costs vary depending on:
- Number of genes tested
- Hospital or testing center grade
- Consultation and counseling fees
Popular Clinics in Korea
- Seoul National University Hospital – Genetic Counseling & Testing Center
- Samsung Medical Center – Hereditary Cancer Screening Program
- Asan Medical Center – Urology & Genetic Testing Department
- Gangnam Severance Hospital – International Patient Genetic Services
- Korea University Anam Hospital – Advanced Genetic Risk Assessment
- JK Urology & Men’s Health Clinics – Prostate Genetic Testing & Counseling
